Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It is, like hepatitis C (HCV), a major global health problem and significant burden on those living with the disease. It can cause chronic liver disease and chronic infection, putting the 350 million people with chronic liver infection at risk of death from cirrhosis of the liver.
While a vaccine against hepatitis B has been available since 1982 and treatments are available to manage his chronic disease, there is no known cure. Given this significant unmet need we are pursuing multiple avenues of research to help combat battle this prevalent, and not yet curable, disease.